查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
傳染病診斷市場規模和預測、全球和地區佔有率、趨勢和成長機會分析（按產品、技術、應用類型、測試類型、最終用戶和地理位置）
市場調查報告書
商品編碼
1389612

傳染病診斷市場規模和預測、全球和地區佔有率、趨勢和成長機會分析（按產品、技術、應用類型、測試類型、最終用戶和地理位置）

Infectious Disease Diagnostics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Technology , Application Type, Testing Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 280 Pages | 訂單完成後即時交付

價格

傳染病診斷市場預計將從2022年的383.66億美元成長到2030年的599.54億美元；預計2022年至2030年CAGR為5.7%。全球傳染病發生率不斷上升，以及獸醫傳染病診斷應用的不斷增加，擴大了傳染病診斷市場規模。然而，報銷不足阻礙了傳染病診斷市場的成長。

傳染病發生率上升推動傳染病診斷市場成長

真菌、病毒、寄生蟲、細菌和有毒產物都是會引起傳染病的傳染原。公共衛生受到傳染病的不利影響，導致發病率、死亡率和經濟負擔。傳染病發病率的上升推動了準確、及時診斷的需求，從而為有效的疾病管理、治療和預防奠定了基礎。可以使用分子診斷技術、實驗室檢測和照護端來診斷和監測多種感染和疾病，包括C型肝炎、HIV、結核病、人類乳突病毒和性傳染感染 (STI) 以及傳染病爆發測試。根據美國疾病管制與預防中心 (CDC) 的數據，非洲國家每年約有 1,020 萬人前往醫生辦公室治療傳染病和寄生蟲病。根據2021年國家醫學圖書館（NLM）發表的一篇文章，由於疾病負擔高和醫療資源有限，傳染病是大多數非洲國家的主要問題。在奈及利亞，超過 200 種病原體會引起發燒，這是前往醫療機構就診的最常見原因之一。根據世界衛生組織 (WHO) 統計，全球約有 5,800 萬人患有慢性C型肝炎感染，每年診斷出約 150 萬名新感染者。愛滋病毒是全世界的重大公共衛生議題。根據聯合國愛滋病毒/愛滋病聯合規劃署 (UNAIDS) 的數據，2020 年，約有 3,770 萬人感染愛滋病毒。其中，約 3,600 萬人是成年人，約 170 萬人是 0-14 歲的兒童。此外，2020 年全球報告了約 150 萬新的愛滋病毒病例。

據世界衛生組織稱，結核病 (TB) 是全球第 13 大死亡原因，也是 COVID-19 之後導致死亡的第二大傳染病。根據世界衛生組織統計，2020年，結核病導致150萬人死亡。世界衛生組織預計，2020年，全球將有1,000萬人罹患結核病。此外，2020年，30個結核病高負擔國家佔結核病新病例的86%。八個國家佔結核病病例總數的三分之二，其中印度位居前列，其次是中國、菲律賓、印尼、奈及利亞、巴基斯坦、孟加拉和南非。因此，傳染病發生率的上升增加了對傳染病診斷技術的需求，例如微生物培養、血凝抑制試驗和酵素連結免疫吸附測定（ELISA）。

該報告將傳染病診斷市場細分如下：

傳染病診斷市場按產品細分為試劑盒和試劑、儀器以及軟體和服務。傳染病診斷市場依技術分為基於生物感測器的診斷、免疫診斷、基於分子的診斷、臨床生物學等。免疫診斷領域的市場進一步細分為酵素連結免疫吸附測定、蛋白質印跡分析和免疫螢光測定。基於分子的診斷技術領域的市場進一步細分為聚合酶鍊式反應、原位雜合技術、等溫核酸擴增技術、次世代定序、DNA微陣列等。傳染病診斷市場依應用類型分為即時檢測和實驗室檢測。傳染病診斷市場依測試類型分為人體測試和獸醫測試。人體檢測市場再細分為愛滋病毒、肝炎、HAIs、HPV、結核病、流感等。依最終用戶分類，傳染病診斷市場分為診斷實驗室、醫院和診所、研究機構、家庭護理機構等。根據地理位置，傳染病診斷市場分為北美（美國、加拿大和墨西哥）、歐洲（英國、德國、法國、義大利、西班牙和歐洲其他地區）、亞太地區（中國、日本） 、印度、韓國、澳洲和亞太地區其他地區）、中東和非洲（阿拉伯聯合大公國、沙烏地阿拉伯、南非以及中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷） ，以及南美洲和中美洲的其他地區）。

基於產品的見解

傳染病診斷市場按產品細分為試劑盒和試劑、儀器以及軟體和服務。 2022年，試劑盒和試劑細分市場佔據最大市場佔有率。然而，軟體和服務領域的市場預計將在 2022 年至 2030 年期間以最快的速度成長。

基於區域的見解

根據地理位置，傳染病診斷市場分為北美、歐洲、亞太地區、中東和非洲以及南美洲和中美洲。北美是全球傳染病診斷市場成長的最大貢獻者。預計 2022 年至 2030 年，亞太地區傳染病診斷市場CAGR最高。美國傳染病診斷市場的成長主要是由傳染病患者病率的增加、老年人口的增加以及主要參與者推出的產品數量的增加所推動的。

Abbott Laboratories、Bruker Corp、Cardinal Health、F. Hoffmann-La Roche Ltd、Trinity Biotech Plc、Danaher Corp、Bio-Rad Laboratories Inc、AccuBioTech Co Ltd、ACON Laboratories 和 DiaSorin SpA 是傳染病領域的知名參與者診斷市場。這些公司專注於新產品發布和地理擴張，以滿足世界各地不斷成長的消費者需求，並擴大其專業產品組合的產品範圍。他們的全球業務使他們能夠為大量客戶提供服務，從而促進市場擴張。

在準備傳染病診斷市場報告時提到的一些主要一手和二手來源包括世界衛生組織 (WHO)、美國人口普查局、《傳染病雜誌》、《國際傳染病雜誌》和 CDC。除此之外。

目錄

第 1 章：簡介 39

  • Insight Partners 研究報告指南。 39
  • 市場區隔. 40

第 2 章：執行摘要 42

  • 重要見解。 42
  • 傳染病診斷市場，依地理分類 43

第 3 章：研究方法 44

  • 覆蓋範圍。 45
  • 二次研究。 45
  • 初步研究。 45

第 4 章：傳染病診斷市場格局 47

  • 概述。 47
  • PEST 分析。 47
    • 全球 PEST 分析。 47

第 5 章：傳染病診斷市場 - 主要產業動態 48

  • 市場促進因素：48
    • 傳染病發生率上升。 48
    • 診斷學在獸醫傳染病的應用不斷增加。 50
  • 市場限制。 50
    • 報銷不足的情況。 50
  • 市場機會。 51
    • 日益關注傳染病診斷的研發和資金。 51
  • 未來的趨勢。 52
    • 產品批准和發布數量不斷增加。 52
  • 影響分析：52

第 6 章：傳染病診斷市場 - 全球市場分析 54

  • 傳染病診斷市場收入，2022 - 2030 年。54

第 7 章：全球傳染病診斷市場 - 收入和 2030 年預測 - 按產品 56

  • 概述。 56
  • 2022 年及 2030 年傳染病診斷市場收入佔有率（按產品）(%) 56
  • 試劑盒和試劑。 57
  • 儀器。 58
  • 軟體和服務。 59

第 8 章：全球傳染病診斷市場 - 收入和 2030 年預測 - 按技術 60

  • 概述。 60
  • 2022 年和 2030 年按技術分類的傳染病診斷市場收入佔有率 (%) 60
  • 基於生物感測器。 61
  • 免疫診斷。 62
  • 基於分子的診斷技術。 64
  • 臨床生物學。 66
  • 其他。 67

第 9 章：全球傳染病診斷市場 - 2030 年收入和預測 -按應用類型 68

  • 概述。 68
  • 2022 年及 2030 年傳染病診斷市場收入佔有率，按應用類型分類 (%) 68
  • 現場護理測試。 69
  • 實驗室測試。 70

第 10 章：全球傳染病診斷市場 - 2030 年收入與預測 - 透過測試 71 型

  • 概述。 71
  • 2022 年和 2030 年傳染病診斷市場收入佔有率，按測試類型分類 (%) 71
  • 人體測試。 72
  • 獸醫測試。 74

第 11 章：全球傳染病診斷市場 - 收入和 2030 年預測 - 按最終用戶 75

  • 概述。 75
  • 2022 年及 2030 年傳染病診斷市場收入佔有率，依最終用戶分類 (%) 75
  • 診斷實驗室。 76
  • 醫院和診所。 77
  • 研究機構。 78
  • 家庭護理設置。 80
  • 其他。 81

第 12 章：傳染病診斷市場 - 地理分析 82

    • 概述。 82
    • 北美：傳染病診斷市場（按產品），2020-2030 83
    • 北美：傳染病診斷市場（按技術）2020-2030 84
      • 北美：傳染病診斷市場，依技術進行免疫診斷，2020-2030 84
      • 北美：傳染病診斷市場，依技術分類的分子診斷技術，2020-2030 85
    • 北美：傳染病診斷市場，依應用類型，2020-2030 85
    • 北美：傳染病診斷市場，依檢驗類型，2020-2030 年 86
      • 北美：傳染病診斷市場，按測試類型分類的人體測試，2020-2030 86
    • 北美：傳染病診斷市場，依最終用戶分類，2020-2030 年 87
    • 北美傳染病診斷市場（按國家/地區）。 87
      • 我們。 88
      • 加拿大。 94
      • 墨西哥。 100
    • 概述。 105
    • 歐洲：傳染病診斷市場（依產品），2020-2030 106
    • 歐洲：傳染病診斷市場（依技術），2020-2030 107
      • 歐洲：傳染病診斷市場，依技術進行免疫診斷，2020-2030 107
      • 歐洲：傳染病診斷市場，依技術分列的分子診斷技術，2020-2030 年 108
    • 歐洲：傳染病診斷市場，依應用類型，2020-2030 108
    • 歐洲：傳染病診斷市場，依檢驗類型，2020-2030 109
      • 歐洲：傳染病診斷市場，依測試類型分類的人體測試，2020-2030 109
    • 歐洲：傳染病診斷市場，依最終使用者分類，2020-2030 年 110
    • 歐洲傳染病診斷市場（按國家）。 110
      • 英國
      • 德國。 117
      • 法國。 123
      • 義大利. 129
      • 西班牙。 134
      • 歐洲其他地區。 139
    • 概述。 145
    • 亞太地區：傳染病診斷市場（依產品），2020-2030 146
    • 亞太地區：傳染病診斷市場（依技術），2020-2030 147
      • 亞太地區：傳染病診斷市場，依技術進行免疫診斷，2020-2030 147
      • 亞太地區：2020-2030 年基於分子的診斷技術的傳染病診斷市場（按技術分類） 148
    • 亞太地區：傳染病診斷市場，依應用類型，2020-2030 年 148
    • 亞太地區：傳染病診斷市場，依測試類型，2020-2030 年 149
      • 亞太地區：傳染病診斷市場，依測試類型分類的人體測試，2020-2030 149
    • 亞太地區：傳染病診斷市場，依最終用戶分類，2020-2030 年 150
    • 亞太傳染病診斷市場（按國家）。 151
      • 中國。 151
      • 日本。 157
      • 印度。 162
      • 韓國。 167
      • 澳大利亞。 172
      • 亞太地區其他地區。 177
    • 概述。 183
    • 中東和非洲：傳染病診斷市場（按產品），2020-2030 184
    • 中東和非洲：傳染病診斷市場（按技術），2020-2030 185
      • 中東和非洲：傳染病診斷市場，依技術進行免疫診斷，2020-2030 185
      • 中東和非洲：2020-2030 年基於分子的診斷技術的傳染病診斷市場 186
    • 中東和非洲：傳染病診斷市場，按應用類型，2020-2030 186
    • 中東和非洲：傳染病診斷市場，按測試類型，2020-2030 年 187
      • 中東和非洲：傳染病診斷市場，按測試類型分類的人體測試，2020-2030 187
    • 中東和非洲：傳染病診斷市場，按最終用戶分類，2020-2030 年 188
      • 中東和非洲傳染病診斷市場（按國家/地區）。 188
      • 沙烏地阿拉伯. 189
      • 南非。 194
      • 阿拉伯聯合大公國。 199
      • 中東和非洲其他地區。 204
    • 概述。 210
    • 南美洲和中美洲：傳染病診斷市場（按產品）2020-2030 211
    • 南美洲和中美洲：傳染病診斷市場（按技術）2020-2030 212
      • 南美洲和中美洲：傳染病診斷市場，依技術進行免疫診斷，2020-2030 212
      • 南美洲和中美洲：傳染病診斷市場，按技術分類的分子診斷技術，2020-2030 年 213
    • 南美洲和中美洲：傳染病診斷市場，按應用類型，2020-2030 年 213
    • 南美洲和中美洲：傳染病診斷市場，按測試類型，2020-2030 年 214
      • 南美洲和中美洲：傳染病診斷市場，按測試類型分類的人體測試，2020-2030 214
    • 南美洲和中美洲：傳染病診斷市場，按最終用戶分類，2020-2030 年 215
    • 南美洲和中美洲傳染病診斷市場（按國家/地區）。 215
      • 巴西 216
Product Code: TIPHE100001430

The infectious disease diagnostics market is expected to grow from US$ 38.366 billion in 2022 to US$ 59.954 billion by 2030; it is anticipated to register a CAGR of 5.7% from 2022 to 2030. The growing incidence of infectious diseases across the world and rising application of diagnostics in veterinary infectious diseases bolster the infectious disease diagnostics market size. However, an inadequate reimbursement scenario hinders the infectious disease diagnostics market growth.

Rising Incidence of Infectious Diseases Drive Infectious Disease Diagnostics Market Growth

Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0-14 years. Also, ~1.5 million new HIV cases were reported globally in 2020.

According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total cases of TB, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).

The report segments the infectious disease diagnostics market as follows:

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Product-Based Insights

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. In 2022, the kits & reagents segment held the largest share of the market. However, the market for the software & services segment is expected to grow at the fastest rate during 2022-2030.

Regional-Based Insights

Based on geography, the infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the global infectious disease diagnostics market. Asia Pacific is expected to register the highest CAGR in the infectious disease diagnostics market during 2022-2030. The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players.

Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.

A few of the major primary and secondary sources referred to while preparing the report on the infectious disease diagnostics market are the World Health Organization (WHO), the US Census Bureau, The Journal for Infectious Diseases, International Journal of Infectious Diseases, and CDC, among others.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the infectious disease diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. 
  • Scrutinize in-depth global infectious disease diagnostics market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction 39

  • 1.1 The Insight Partners Research Report Guidance. 39
  • 1.2 Market Segmentation. 40

2. Executive Summary 42

  • 2.1 Key Insights. 42
  • 2.2 Infectious Disease Diagnostics Market, by Geography (US$ Million) 43

3. Research Methodology 44

  • 3.1 Coverage. 45
  • 3.2 Secondary Research. 45
  • 3.3 Primary Research. 45

4. Infectious Disease Diagnostics Market Landscape 47

  • 4.1 Overview. 47
  • 4.2 PEST Analysis. 47
    • 4.2.1 Global PEST Analysis. 47

5. Infectious Disease Diagnostics Market - Key Industry Dynamics 48

  • 5.1 Market Drivers: 48
    • 5.1.1 Rising Incidence of Infectious Diseases. 48
    • 5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease. 50
  • 5.2 Market Restraints. 50
    • 5.2.1 Inadequate Reimbursement Scenario. 50
  • 5.3 Market Opportunities. 51
    • 5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics. 51
  • 5.4 Future Trends. 52
    • 5.4.1 Rising Number of Product Approvals and Launches. 52
  • 5.5 Impact Analysis: 52

6. Infectious Disease Diagnostics Market - Global Market Analysis 54

  • 6.1 Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030. 54

7. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product 56

  • 7.1 Overview. 56
  • 7.2 Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
  • 7.3 Kits & Reagents. 57
    • 7.3.1 Overview. 57
    • 7.3.2 Kits & Reagents: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 57
  • 7.4 Instruments. 58
    • 7.4.1 Overview. 58
    • 7.4.2 Instruments: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 58
  • 7.5 Software & Services. 59
    • 7.5.1 Overview. 59
    • 7.5.2 Software & Services: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 59

8. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology 60

  • 8.1 Overview. 60
  • 8.2 Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
  • 8.3 Biosensor-based. 61
    • 8.3.1 Overview. 61
    • 8.3.2 Biosensor-based: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 61
  • 8.4 Immunodiagnostics. 62
    • 8.4.1 Overview. 62
    • 8.4.2 Immunodiagnostics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 62
      • 8.4.2.1 Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 63
  • 8.5 Molecular-Based Diagnostic Techniques. 64
    • 8.5.1 Overview. 64
    • 8.5.2 Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 64
      • 8.5.2.1 Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 64
  • 8.6 Clinical Biology. 66
    • 8.6.1 Overview. 66
    • 8.6.2 Clinical Biology: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 66
  • 8.7 Others. 67
    • 8.7.1 Overview. 67
    • 8.7.2 Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 67

9. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type 68

  • 9.1 Overview. 68
  • 9.2 Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
  • 9.3 Point-of-Care Testing. 69
    • 9.3.1 Overview. 69
    • 9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 69
  • 9.4 Laboratory Testing. 70
    • 9.4.1 Overview. 70
    • 9.4.2 Laboratory Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 70

10. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type 71

  • 10.1 Overview. 71
  • 10.2 Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
  • 10.3 Human Testing. 72
    • 10.3.1 Overview. 72
    • 10.3.2 Human Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 72
      • 10.3.2.1 Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 73
  • 10.4 Veterinary Testing. 74
    • 10.4.1 Overview. 74
    • 10.4.2 Veterinary Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 74

11. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User 75

  • 11.1 Overview. 75
  • 11.2 Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
  • 11.3 Diagnostic Laboratories. 76
    • 11.3.1 Overview. 76
    • 11.3.2 Diagnostic Laboratories: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 76
  • 11.4 Hospitals and Clinics. 77
    • 11.4.1 Overview. 77
    • 11.4.2 Hospitals and Clinics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 77
  • 11.5 Research Institutes. 78
    • 11.5.1 Overview. 78
    • 11.5.2 Research Institutes: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 78
  • 11.6 Homecare Settings. 80
    • 11.6.1 Overview. 80
    • 11.6.2 Homecare Settings: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 80
  • 11.7 Others. 81
    • 11.7.1 Overview. 81
    • 11.7.2 Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 81

12. Infectious Disease Diagnostics Market - Geographical Analysis 82

  • 12.1 North America Infectious Disease Diagnostics Market, Revenue and Forecast To 2030. 82
    • 12.1.1 Overview. 82
    • 12.1.2 North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
    • 12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 83
    • 12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 84
      • 12.1.4.1 North America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 84
      • 12.1.4.2 North America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 85
    • 12.1.5 North America: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 85
    • 12.1.6 North America: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 86
      • 12.1.6.1 North America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 86
    • 12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 87
    • 12.1.8 North America Infectious Disease Diagnostics Market, by Country. 87
      • 12.1.8.1 US. 88
        • 12.1.8.1.1 Overview
        • 12.1.8.1.2 US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
        • 12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 88
        • 12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 90
        • 12.1.8.1.4.1 US: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 90
        • 12.1.8.1.4.2 US: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 91
        • 12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 92
        • 12.1.8.1.6 US: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 92
        • 12.1.8.1.6.1 US: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 92
        • 12.1.8.1.7 US: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 93
      • 12.1.8.2 Canada. 94
        • 12.1.8.2.1 Overview
        • 12.1.8.2.2 Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
        • 12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 95
        • 12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 96
        • 12.1.8.2.4.1 Canada: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 96
        • 12.1.8.2.4.2 Canada: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 97
        • 12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 97
        • 12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 98
        • 12.1.8.2.6.1 Canada: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 98
        • 12.1.8.2.7 Canada: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 99
      • 12.1.8.3 Mexico. 100
        • 12.1.8.3.1 Overview
        • 12.1.8.3.2 Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
        • 12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 101
        • 12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 102
        • 12.1.8.3.4.1 Mexico: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 102
        • 12.1.8.3.4.2 Mexico: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 103
        • 12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 103
        • 12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 103
        • 12.1.8.3.6.1 Mexico: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 104
        • 12.1.8.3.7 Mexico: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 104
  • 12.2 Europe Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 105
    • 12.2.1 Overview. 105
    • 12.2.2 Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
    • 12.2.3 Europe: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 106
    • 12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 107
      • 12.2.4.1 Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 107
      • 12.2.4.2 Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 108
    • 12.2.5 Europe: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 108
    • 12.2.6 Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 109
      • 12.2.6.1 Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 109
    • 12.2.7 Europe: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 110
    • 12.2.8 Europe Infectious Disease Diagnostics Market, by Country. 110
      • 12.2.8.1 UK
        • 12.2.8.1.1 Overview
        • 12.2.8.1.2 UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
        • 12.2.8.1.3 UK: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 111
        • 12.2.8.1.4 UK: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 113
        • 12.2.8.1.4.1 UK: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 113
        • 12.2.8.1.4.2 UK: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 114
        • 12.2.8.1.5 UK: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 114
        • 12.2.8.1.6 UK: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 115
        • 12.2.8.1.6.1 UK: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 115
        • 12.2.8.1.7 UK: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 116
      • 12.2.8.2 Germany. 117
        • 12.2.8.2.1 Overview
        • 12.2.8.2.2 Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
        • 12.2.8.2.3 Germany: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 118
        • 12.2.8.2.4 Germany: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 119
        • 12.2.8.2.4.1 Germany: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 119
        • 12.2.8.2.4.2 Germany: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 120
        • 12.2.8.2.5 Germany: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 120
        • 12.2.8.2.6 Germany: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 121
        • 12.2.8.2.6.1 Germany: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 121
        • 12.2.8.2.7 Germany: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 122
      • 12.2.8.3 France. 123
        • 12.2.8.3.1 Overview
        • 12.2.8.3.2 France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
        • 12.2.8.3.3 France: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 123
        • 12.2.8.3.4 France: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 125
        • 12.2.8.3.4.1 France: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 125
        • 12.2.8.3.4.2 France: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 126
        • 12.2.8.3.5 France: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 126
        • 12.2.8.3.6 France: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 127
        • 12.2.8.3.6.1 France: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 127
        • 12.2.8.3.7 France: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 128
      • 12.2.8.4 Italy. 129
        • 12.2.8.4.1 Overview
        • 12.2.8.4.2 Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
        • 12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 129
        • 12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 131
        • 12.2.8.4.4.1 Italy: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 131
        • 12.2.8.4.4.2 Italy: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 132
        • 12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 132
        • 12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 132
        • 12.2.8.4.6.1 Italy: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 133
        • 12.2.8.4.7 Italy: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 133
      • 12.2.8.5 Spain. 134
        • 12.2.8.5.1 Overview
        • 12.2.8.5.2 Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
        • 12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 134
        • 12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 136
        • 12.2.8.5.4.1 Spain: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 136
        • 12.2.8.5.4.2 Spain: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 137
        • 12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 137
        • 12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 137
        • 12.2.8.5.6.1 Spain: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 138
        • 12.2.8.5.7 Spain: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 138
      • 12.2.8.6 Rest of Europe. 139
        • 12.2.8.6.1 Overview
        • 12.2.8.6.2 Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
        • 12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 139
        • 12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 141
        • 12.2.8.6.4.1 Rest of Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 141
        • 12.2.8.6.4.2 Rest of Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 142
        • 12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 142
        • 12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 143
        • 12.2.8.6.6.1 Rest of Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 143
        • 12.2.8.6.7 Rest of Europe: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 144
  • 12.3 Asia Pacific Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 145
    • 12.3.1 Overview. 145
    • 12.3.2 Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
    • 12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 146
    • 12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 147
      • 12.3.4.1 Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 147
      • 12.3.4.2 Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 148
    • 12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 148
    • 12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 149
      • 12.3.6.1 Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 149
    • 12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 150
    • 12.3.8 Asia Pacific Infectious Disease Diagnostics Market, by Country. 151
      • 12.3.8.1 China. 151
        • 12.3.8.1.1 Overview
        • 12.3.8.1.2 China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
        • 12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 153
        • 12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 153
        • 12.3.8.1.4.1 China: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 154
        • 12.3.8.1.4.2 China: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 154
        • 12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 155
        • 12.3.8.1.6 China: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 155
        • 12.3.8.1.6.1 China: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 156
        • 12.3.8.1.7 China: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 156
      • 12.3.8.2 Japan. 157
        • 12.3.8.2.1 Overview
        • 12.3.8.2.2 Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
        • 12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 157
        • 12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 159
        • 12.3.8.2.4.1 Japan: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 159
        • 12.3.8.2.4.2 Japan: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 160
        • 12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 160
        • 12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 160
        • 12.3.8.2.6.1 Japan: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 161
        • 12.3.8.2.7 Japan: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 161
      • 12.3.8.3 India. 162
        • 12.3.8.3.1 Overview
        • 12.3.8.3.2 India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
        • 12.3.8.3.3 India: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 162
        • 12.3.8.3.4 India: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 164
        • 12.3.8.3.4.1 India: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 164
        • 12.3.8.3.4.2 India: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 165
        • 12.3.8.3.5 India: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 165
        • 12.3.8.3.6 India: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 165
        • 12.3.8.3.6.1 India: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 166
        • 12.3.8.3.7 India: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 166
      • 12.3.8.4 South Korea. 167
        • 12.3.8.4.1 Overview
        • 12.3.8.4.2 South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
        • 12.3.8.4.3 South Korea: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 167
        • 12.3.8.4.4 South Korea: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 169
        • 12.3.8.4.4.1 South Korea: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 169
        • 12.3.8.4.4.2 South Korea: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 170
        • 12.3.8.4.5 South Korea: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 170
        • 12.3.8.4.6 South Korea: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 170
        • 12.3.8.4.6.1 South Korea: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 171
        • 12.3.8.4.7 South Korea: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 171
      • 12.3.8.5 Australia. 172
        • 12.3.8.5.1 Overview
        • 12.3.8.5.2 Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
        • 12.3.8.5.3 Australia: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 172
        • 12.3.8.5.4 Australia: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 174
        • 12.3.8.5.4.1 Australia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 174
        • 12.3.8.5.4.2 Australia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 175
        • 12.3.8.5.5 Australia: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 175
        • 12.3.8.5.6 Australia: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 175
        • 12.3.8.5.6.1 Australia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 176
        • 12.3.8.5.7 Australia: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 176
      • 12.3.8.6 Rest of Asia Pacific. 177
        • 12.3.8.6.1 Overview
        • 12.3.8.6.2 Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
        • 12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 177
        • 12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 179
        • 12.3.8.6.4.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 179
        • 12.3.8.6.4.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 180
        • 12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 180
        • 12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 181
        • 12.3.8.6.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 181
        • 12.3.8.6.7 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 182
  • 12.4 Middle East & Africa Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 183
    • 12.4.1 Overview. 183
    • 12.4.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
    • 12.4.3 Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 184
    • 12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 185
      • 12.4.4.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 185
      • 12.4.4.2 Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 186
    • 12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 186
    • 12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 187
      • 12.4.6.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 187
    • 12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 188
      • 12.4.7.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country. 188
      • 12.4.7.2 Saudi Arabia. 189
        • 12.4.7.2.1 Overview
        • 12.4.7.2.2 Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
        • 12.4.7.2.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 189
        • 12.4.7.2.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 191
        • 12.4.7.2.4.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 191
        • 12.4.7.2.4.2 Saudi Arabia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 192
        • 12.4.7.2.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 192
        • 12.4.7.2.6 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 192
        • 12.4.7.2.6.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 193
        • 12.4.7.2.7 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 193
      • 12.4.7.3 South Africa. 194
        • 12.4.7.3.1 Overview
        • 12.4.7.3.2 South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
        • 12.4.7.3.3 South Africa: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 194
        • 12.4.7.3.4 South Africa: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 196
        • 12.4.7.3.4.1 South Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 196
        • 12.4.7.3.4.2 South Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 197
        • 12.4.7.3.5 South Africa: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 197
        • 12.4.7.3.6 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 197
        • 12.4.7.3.6.1 South Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 198
        • 12.4.7.3.7 South Africa: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 198
      • 12.4.7.4 UAE. 199
        • 12.4.7.4.1 Overview
        • 12.4.7.4.2 UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
        • 12.4.7.4.3 UAE: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 199
        • 12.4.7.4.4 UAE: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 201
        • 12.4.7.4.4.1 UAE: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 201
        • 12.4.7.4.4.2 UAE: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 202
        • 12.4.7.4.5 UAE: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 202
        • 12.4.7.4.6 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 202
        • 12.4.7.4.6.1 UAE: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 203
        • 12.4.7.4.7 UAE: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 203
      • 12.4.7.5 Rest of Middle East & Africa. 204
        • 12.4.7.5.1 Overview
        • 12.4.7.5.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
        • 12.4.7.5.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 204
        • 12.4.7.5.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 206
        • 12.4.7.5.4.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 206
        • 12.4.7.5.4.2 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 207
        • 12.4.7.5.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 207
        • 12.4.7.5.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 208
        • 12.4.7.5.6.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 208
        • 12.4.7.5.7 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 209
  • 12.5 South & Central America Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 210
    • 12.5.1 Overview. 210
    • 12.5.2 South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
    • 12.5.3 South & Central America: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 211
    • 12.5.4 South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 212
      • 12.5.4.1 South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 212
      • 12.5.4.2 South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 213
    • 12.5.5 South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 213
    • 12.5.6 South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 214
      • 12.5.6.1 South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 214
    • 12.5.7 South & Central America: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 215
    • 12.5.8 South & Central America Infectious Disease Diagnostics Market, by Country. 215
      • 12.5.8.1 Brazil 216
        • 12.5.8.1.1 Overview
        • 12.5.8.1.2 Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
        • 12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 216
        • 12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 218
        • 12.5.8.1.4.1 Brazil: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 218
        • 12.5.8.1.4.2 Brazil: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 219
        • 12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 219
        • 12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 219
        • 12.5.8.1.6.1 Brazil: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 220
        • 12.5.8.1.7 Brazil: Infectious Disease Diagnostics Market, by End Use

List Of Tables

  • Table 1. Infectious Disease Diagnostics Market Segmentation. 40
  • Table 2. Infectious Diseases and Fundings. 51
  • Table 3. Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 63
  • Table 4. Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 64
  • Table 5. Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 73
  • Table 6. North America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 83
  • Table 7. North America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 84
  • Table 8. North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 84
  • Table 9. North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 85
  • Table 10. North America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 85
  • Table 11. North America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 86
  • Table 12. North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 86
  • Table 13. North America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 87
  • Table 14. US Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 88
  • Table 15. US Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 90
  • Table 16. US Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 90
  • Table 17. US Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 91
  • Table 18. US Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 92
  • Table 19. US Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 92
  • Table 20. US Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 92
  • Table 21. US Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 93
  • Table 22. Canada Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 95
  • Table 23. Canada Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 96
  • Table 24. Canada Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 96
  • Table 25. Canada Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 97
  • Table 26. Canada Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 97
  • Table 27. Canada Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 98
  • Table 28. Canada Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 98
  • Table 29. Canada Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 99
  • Table 30. Mexico Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 101
  • Table 31. Mexico Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 102
  • Table 32. Mexico Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 102
  • Table 33. Mexico Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 103
  • Table 34. Mexico Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 103
  • Table 35. Mexico Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 103
  • Table 36. Mexico Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 104
  • Table 37. Mexico Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 104
  • Table 38. Europe Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 106
  • Table 39. Europe Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 107
  • Table 40. Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 107
  • Table 41. Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 108
  • Table 42. Europe Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 108
  • Table 43. Europe Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 109
  • Table 44. Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 109
  • Table 45. Europe Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 110
  • Table 46. UK Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 111
  • Table 47. UK Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 113
  • Table 48. UK Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 113
  • Table 49. UK Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 114
  • Table 50. UK Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 114
  • Table 51. UK Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 115
  • Table 52. UK Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 115
  • Table 53. UK Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 116
  • Table 54. Germany Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 118
  • Table 55. Germany Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 119
  • Table 56. Germany Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 119
  • Table 57. Germany Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 120
  • Table 58. Germany Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 120
  • Table 59. Germany Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 121
  • Table 60. Germany Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 121
  • Table 61. Germany Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 122
  • Table 62. France Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 123
  • Table 63. France Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 125
  • Table 64. France Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 125
  • Table 65. France Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 126
  • Table 66. France Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 126
  • Table 67. France Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 127
  • Table 68. France Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 127
  • Table 69. France Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 128
  • Table 70. Italy Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 129
  • Table 71. Italy Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 131
  • Table 72. Italy Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 131
  • Table 73. Italy Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 132
  • Table 74. Italy Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 132
  • Table 75. Italy Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 132
  • Table 76. Italy Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 133
  • Table 77. Italy Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 133
  • Table 78. Spain Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 134
  • Table 79. Spain Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 136
  • Table 80. Spain Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 136
  • Table 81. Spain Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 137
  • Table 82. Spain Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 137
  • Table 83. Spain Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 137
  • Table 84. Spain Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 138
  • Table 85. Spain Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 138
  • Table 86. Rest of Europe Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 140
  • Table 87. Rest of Europe Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 141
  • Table 88. Rest of Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 141
  • Table 89. Rest of Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 142
  • Table 90. Rest of Europe Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 142
  • Table 91. Rest of Europe Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 143
  • Table 92. Rest of Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 143
  • Table 93. Rest of Europe Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 144
  • Table 94. Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 146
  • Table 95. Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 147
  • Table 96. Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 147
  • Table 97. Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 148
  • Table 98. Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 148
  • Table 99. Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 149
  • Table 100. Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 149
  • Table 101. Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 150
  • Table 102. China Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 153
  • Table 103. China Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 153
  • Table 104. China Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 154
  • Table 105. China Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 154
  • Table 106. China Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 155
  • Table 107. China Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 155
  • Table 108. China Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 156
  • Table 109. China Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 156
  • Table 110. Japan Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 157
  • Table 111. Japan Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 159
  • Table 112. Japan Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 159
  • Table 113. Japan Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 160
  • Table 114. Japan Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 160
  • Table 115. Japan Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 160
  • Table 116. Japan Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 161
  • Table 117. Japan Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 161
  • Table 118. India Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 162
  • Table 119. India Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 164
  • Table 120. India Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 164
  • Table 121. India Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 165
  • Table 122. India Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 165
  • Table 123. India Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 165
  • Table 124. India Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 166
  • Table 125. India Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 166
  • Table 126. South Korea Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 167
  • Table 127. South Korea Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 169
  • Table 128. South Korea Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 169
  • Table 129. South Korea Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 170
  • Table 130. South Korea Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 170
  • Table 131. South Korea Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 170
  • Table 132. South Korea Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 171
  • Table 133. South Korea Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 171
  • Table 134. Australia Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 172
  • Table 135. Australia Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 174
  • Table 136. Australia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 174
  • Table 137. Australia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 175
  • Table 138. Australia Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 175
  • Table 139. Australia Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 175
  • Table 140. Australia Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 176
  • Table 141. Australia Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 176
  • Table 142. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 177
  • Table 143. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 179
  • Table 144. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 179
  • Table 145. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 180
  • Table 146. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 180
  • Table 147. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 181
  • Table 148. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 181
  • Table 149. Rest of Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 182
  • Table 150. Middle East & Africa Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 184
  • Table 151. Middle East & Africa Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 185
  • Table 152. Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 185
  • Table 153. Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 186
  • Table 154. Middle East & Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 186
  • Table 155. Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 187
  • Table 156. Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 187
  • Table 157. Middle East & Africa Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 188
  • Table 158. Saudi Arabia Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 189
  • Table 159. Saudi Arabia Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 191
  • Table 160. Saudi Arabia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 191
  • Table 161. Saudi Arabia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 192
  • Table 162. Saudi Arabia Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 192
  • Table 163. Saudi Arabia Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 192
  • Table 164. Saudi Arabia Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 193
  • Table 165. Saudi Arabia Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 193
  • Table 166. Saudi Arabia Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 194
  • Table 167. South Africa Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 196
  • Table 168. South Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 196
  • Table 169. South Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 197
  • Table 170. South Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 197
  • Table 171. South Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 197
  • Table 172. South Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 198
  • Table 173. South Africa Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 198
  • Table 174. UAE Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 199
  • Table 175. UAE Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 201
  • Table 176. UAE Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 201
  • Table 177. UAE Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 202
  • Table 178. UAE Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 202
  • Table 179. UAE Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 202
  • Table 180. UAE Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 203
  • Table 181. UAE Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 203
  • Table 182. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 204
  • Table 183. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 206
  • Table 184. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 206
  • Table 185. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 207
  • Table 186. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 207
  • Table 187. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 208
  • Table 188. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 208
  • Table 189. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 209
  • Table 190. South & Central America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 211
  • Table 191. South & Central America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 212
  • Table 192. South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 212
  • Table 193. South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 213
  • Table 194. South & Central America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 213
  • Table 195. South & Central America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 214
  • Table 196. South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 214
  • Table 197. South & Central America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 215
  • Table 198. Brazil Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 216
  • Table 199. Brazil Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 218
  • Table 200. Brazil Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 218
  • Table 201. Brazil Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 219
  • Table 202. Brazil Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 219
  • Table 203. Brazil Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 219
  • Table 204. Brazil Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 220
  • Table 205. Brazil Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 220
  • Table 206. Argentina Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 221
  • Table 207. Argentina Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 223
  • Table 208. Argentina Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 223
  • Table 209. Argentina Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 224
  • Table 210. Argentina Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 224
  • Table 211. Argentina Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 224
  • Table 212. Argentina Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 225
  • Table 213. Argentina Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 225
  • Table 214. Rest of South & Central America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 226
  • Table 215. Rest of South & Central America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 227
  • Table 216. Rest of South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 227
  • Table 217. Rest of South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 228
  • Table 218. Rest of South & Central America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 228
  • Table 219. Rest of South & Central America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 229
  • Table 220. Rest of South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 229
  • Table 221. Rest of South & Central America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 230
  • Table 222. Organic Developments Done By Companies. 232
  • Table 223. Inorganic Developments Done By Companies. 234
  • Table 224. Glossary of Terms, Infectious Disease Diagnostics Market 278

List Of Figures

  • Figure 1. Infectious Disease Diagnostics Market Segmentation, By Geography. 41
  • Figure 2. Global - PEST Analysis. 47
  • Figure 3. Infectious Disease Diagnostics Market - Key Industry Dynamics. 48
  • Figure 4. Impact Analysis of Drivers and Restraints. 53
  • Figure 5. Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030. 54
  • Figure 6. Infectious Disease Diagnostics Market Revenue, Geography (US$ Mn), 2022 - 2030. 55
  • Figure 7. Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
  • Figure 8. Kits & Reagents: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 57
  • Figure 9. Instruments: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 58
  • Figure 10. Software & Services: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 59
  • Figure 11. Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
  • Figure 12. Biosensor-based: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 61
  • Figure 13. Immunodiagnostics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 62
  • Figure 14. Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 64
  • Figure 15. Clinical Biology: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 66
  • Figure 16. Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 67
  • Figure 17. Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
  • Figure 18. Point-of-Care Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 69
  • Figure 19. Laboratory Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 70
  • Figure 20. Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
  • Figure 21. Human Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 72
  • Figure 22. Veterinary Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 74
  • Figure 23. Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
  • Figure 24. Diagnostic Laboratories: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 76
  • Figure 25. Hospitals and Clinics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 77
  • Figure 26. Research Institutes: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 78
  • Figure 27. Homecare Settings: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 80
  • Figure 28. Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 81
  • Figure 29. North America: Infectious Disease Diagnostics Market, by Key Country - Revenue (2022) (US$ Million) 82
  • Figure 30. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
  • Figure 31. North America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 87
  • Figure 32. US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
  • Figure 33. Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
  • Figure 34. Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
  • Figure 35. Europe Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million) 105
  • Figure 36. Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
  • Figure 37. Europe Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 110
  • Figure 38. UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
  • Figure 39. Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
  • Figure 40. France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
  • Figure 41. Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
  • Figure 42. Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
  • Figure 43. Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
  • Figure 44. Asia Pacific Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million) 145
  • Figure 45. Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
  • Figure 46. Asia Pacific Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 151
  • Figure 47. China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
  • Figure 48. Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
  • Figure 49. India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
  • Figure 50. South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
  • Figure 51. Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
  • Figure 52. Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
  • Figure 53. Middle East & Africa Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million) 183
  • Figure 54. Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
  • Figure 55. Middle East & Africa Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 188
  • Figure 56. Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
  • Figure 57. South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
  • Figure 58. UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
  • Figure 59. Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
  • Figure 60. South & Central America Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million) 210
  • Figure 61. South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
  • Figure 62. South & Central America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 215
  • Figure 63. Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
  • Figure 64. Argentina Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 221
  • Figure 65. Rest of South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 226
  • Figure 66. Growth Strategies Done by the Companies in the Market, (%) 231